Success Metrics

Clinical Success Rate
93.7%

Based on 134 completed trials

Completion Rate
94%(134/143)
Active Trials
8(5%)
Results Posted
28%(38 trials)
Terminated
9(5%)

Phase Distribution

Ph phase_2
20
12%
Ph not_applicable
11
6%
Ph phase_1
119
70%
Ph early_phase_1
2
1%
Ph phase_4
4
2%
Ph phase_3
14
8%

Phase Distribution

121

Early Stage

20

Mid Stage

18

Late Stage

Phase Distribution170 total trials
Early Phase 1First-in-human
2(1.2%)
Phase 1Safety & dosage
119(70.0%)
Phase 2Efficacy & side effects
20(11.8%)
Phase 3Large-scale testing
14(8.2%)
Phase 4Post-market surveillance
4(2.4%)
N/ANon-phased studies
11(6.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.5%

134 of 148 finished

Non-Completion Rate

9.5%

14 ended early

Currently Active

8

trials recruiting

Total Trials

170

all time

Status Distribution
Active(18)
Completed(134)
Terminated(14)
Other(4)

Detailed Status

Completed134
Not yet recruiting10
Terminated9
Recruiting5
Withdrawn5
unknown4

Development Timeline

Analytics

Development Status

Total Trials
170
Active
8
Success Rate
93.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.2%)
Phase 1119 (70.0%)
Phase 220 (11.8%)
Phase 314 (8.2%)
Phase 44 (2.4%)
N/A11 (6.5%)

Trials by Status

recruiting53%
not_yet_recruiting106%
withdrawn53%
terminated95%
unknown42%
active_not_recruiting32%
completed13479%

Recent Activity

Clinical Trials (170)

Showing 20 of 170 trialsScroll for more
NCT05766267Phase 2

Short-course Regimens for the Treatment of Pulmonary Tuberculosis

Active Not Recruiting
NCT07253688Phase 3

Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus

Terminated
NCT05098041Phase 1

A Study of Soticlestat and Rifampin in Healthy Adults

Completed
NCT07800897Phase 1

A Study of Navlimetostat (BMS-986504) Drug Interactions and Food Effect in Healthy Participants

Not Yet Recruiting
NCT02563327Phase 3

Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis

Completed
NCT07595042Phase 2

A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)

Not Yet Recruiting
NCT07770217Phase 1

A Phase I Clinical Trial to Evaluate Pharmacokinetics of HS-10504

Not Yet Recruiting
NCT05221502Phase 2

Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB

Completed
NCT07600775Phase 1

A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)

Not Yet Recruiting
NCT06253715Phase 3

Shortened Regimen for Drug-susceptible TB in Children

Recruiting
NCT06489431Phase 3

Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement

Active Not Recruiting
NCT07242781Phase 1

A Study to Evaluate the Effect of Itraconazole and Rifampin on the Drug Levels of AR-LDD (BMS-986365) in Healthy Adult Male Participants

Terminated
NCT04933682Phase 1

Drug Interaction Study of ALXN2050 With Fluconazole and Rifampin in Healthy Adult Participants

Completed
NCT03301038Phase 2

Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria

Recruiting
NCT07550621Phase 1

Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participants

Not Yet Recruiting
NCT03012529Phase 4

Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics

Completed
NCT03672630Phase 2

Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease

Completed
NCT07357610Phase 1

An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants

Recruiting
NCT04951986Phase 3

Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis

Active Not Recruiting
NCT05592223Phase 1

Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines

Completed

Drug Details

Intervention Type
DRUG
Total Trials
170